Hemochromatosis News

Key risk factors that may predict severe disease in patients with MIS-C include fever greater than 103.1 degrees Fahrenheit, central nervous system involvement and left ventricular dysfunction, according to data published in Rheumatology.

Healio announced the launch of Rheum and Boards, a quiz-based, online learning resource for rheumatologists, according to a Healio press release.

This past spring, two studies shed light on how some of the largest clinician organizations and publishers in rheumatology, including the American College of Rheumatology and EULAR, have failed to provide adequate training materials or clear guidelines when it comes to caring for patients of color.

Why is hemochromatosis so common? What is iron actually doing to the joint? Does phlebotomy help? What’s going on with iron and Popeye? These are the questions we tackle in the second episode of hemochromatosis: Iron and Bone!

In this episode, we dig into hemochromatosis to better understand what it is, how it affects the joints, available screening methods, as well as clues to presentation and physical exam findings.

The COVID-19 pandemic, in places like Detroit, with a large working-class population, can highlight the gap between the rich and the poor. It can demonstrate how political unrest can impact the response to a critical situation. Moreover, it can show how health care workers can face both personal and professional challenges in managing an outbreak of this magnitude.

The very idea of social distancing runs contrary to congregation and celebration, two things that lie at the core of New Orleans culture. It is for this reason, perhaps, that New Orleanians were initially resistant to quarantine measures to contain COVID-19. But as the death toll climbed and Mayor LaToya Cantrell canceled St. Patrick’s Day festivities, the city slowly awakened to the idea that this was serious business.

A newly formed organization, the COVID-19 Global Rheumatology Alliance, has launched an international registry to collect data on patients with rheumatic diseases who may or may not have contracted the infection that is causing the global pandemic. The aim is to aid clinicians and researchers in real time as the situation evolves.

The situation with COVID-19, or the currently circulating coronavirus, is developing so rapidly that new information may likely be available by the time you reach the end of this paragraph. But along with factual information, misinformation also abounds on social media, on cable news channels and in print publications. Healio Rheumatology will attempt to set the record straight for health care providers looking to sort out fact from fiction.